跳至主要内容
临床试验/JPRN-jRCTs051180026
JPRN-jRCTs051180026已完成2 期

Prospective, randomized, double-blind, placebo-controlled trial in nutritional support for autologous PBSCT Non-synbiotics vs synbiotics

Minami Hironobu0 个研究点目标入组 12 人开始时间: 2019年1月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

Our study suggests that Gfine can be given safely and may be effective against gastrointestinal toxicity in the patients received high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Because our study is a pilot study, future studies with a larger number of patients are required.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 65age old(—)
性别
All

入选标准

  • (1) Malignant lymphoma who can be candidate for autologous PBSCT
  • (2) 17(3) ECOG PS <2
  • (4) No obvious organ failure
  • (5) They have given written informed consent
  • (6) Patients who will survive more than 3 months

排除标准

  • (1) History of stem cell transplantation
  • (2) HIV carrier
  • (3) Uncontrolled active infectious diseases
  • (4) Pregnant or lactating
  • (5) Uncontrolled psychological disorder
  • (6) Allergy for the drugs used for the conditioning regimen
  • (7) Allergy for Gfine
  • (8) Patients who do not tolerate the maximal defined conditioning regimen due to organ dysfunction (e.g., reduce MCNU due to pulmonary dysfunction, reduce Carboplatin due to renal dysfunction)
  • (9) Patients who do not ingest enough calories
  • (10) Investigator rejection

研究者

发起方
Minami Hironobu

相似试验